Nitric oxide (NO) is a radical effector molecule with diverse roles, including neurotransmission, vasodilation, and immune killing. NO is made by several isoforms of NO synthase (NOS). The constitutive NOS isoforms are restricted to endothelial cells and neurons, but the inducible NOS isoform, first found in macrophages, occurs in many cell types and perhaps can be expressed in all types. The activity of the inducible NOS is an order of magnitude greater than that of the constitutive isoforms, and NO produced in large quantities can kill or inhibit the growth of a variety of pathogens, including bacteria, fungi, and parasites. NO is particularly effective in blocking the growth of intracellular pathogens, and since the host response to viral infection includes production of cytokines that induce NOS, NO might also play a role in the immune response to viruses. Coxsackievirus infects the hearts of mice and humans. Although the natural history of coxsackievirus myocarditis in humans is not well defined, in mice the severity and duration of coxsackievirus myocarditis is determined by a variety of factors. The host response to coxsackievirus infection is mediated by lymphocytes, macrophages. To explore the hypotheses that viruses induce NOS and that NO inhibits viral replication in myocarditis, the following issues will be examined.
Specific aim #1 : How does NO inhibit viral replication in vitro? Preliminary data suggest that NO inhibits viral replication in vitro. The anti-viral mechanism of NO will be explored by examining the effect of NO on various stages of the viral replicative cycle, including virus binding to the host cell, penetration, translation, transcription, and viral exit.
Specific aim #2 : What is the role of NO in murine viral myocarditis? Preliminary data show that viral infection induces NOS in murine hearts, and that inhibiting NOS permits viral replication to increase. The induction of NOS and production of NO will be explored during the acute phase of myocarditis in B 1O.A mice infected with coxsackievirus B3. The effect of administering NOS inhibitors or NO donors on viral replication, inflammation, and mortality will be measured. These experiments will show whether NO generated during viral infection inhibits viral replication in vivo, damages the host, or both.
Specific aim #3 : Is NOS induced in human viral myocarditis? Using an antibody to human induced NOS, immunohistochemistry will screen for the expression of NOS in endomyocardial biopsy specimens and explanted hearts from patients with and without myocarditis. These studies will help to define the anti-viral mechanism of NO, and the role of NO in defending the host against viral infections.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL053615-02
Application #
2378833
Study Section
Special Emphasis Panel (ZRG4-CVA (02))
Project Start
1996-03-01
Project End
2000-02-29
Budget Start
1997-03-01
Budget End
1998-02-28
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Bhatia, Rinky; Matsushita, Kenji; Yamakuchi, Munekazu et al. (2004) Ceramide triggers Weibel-Palade body exocytosis. Circ Res 95:319-24
Cao, Wangsen; Bao, Clare; Lowenstein, Charles J (2003) Inducible nitric oxide synthase expression inhibition by adenovirus E1A. Proc Natl Acad Sci U S A 100:7773-8
Lopez-Ongil, S; Saura, M; Zaragoza, C et al. (2002) Hydrogen peroxide regulation of bovine endothelin-converting enzyme-1. Free Radic Biol Med 32:406-13
Saura, Marta; Zaragoza, Carlos; Cao, Wangsen et al. (2002) Smad2 mediates transforming growth factor-beta induction of endothelial nitric oxide synthase expression. Circ Res 91:806-13
Tendler, D S; Bao, C; Wang, T et al. (2001) Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res 61:3682-8
Qian, Z; Gelzer-Bell, R; Yang Sx, S X et al. (2001) Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection. Circulation 104:2369-75
Horton, M R; Olman, M A; Bao, C et al. (2000) Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Mol Physiol 279:L707-15
Zaragoza, C; Ocampo, C J; Saura, M et al. (1999) Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. J Immunol 163:5497-504
Saura, M; Zaragoza, C; Bao, C et al. (1999) Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J Mol Biol 289:459-71
Saura, M; Zaragoza, C; McMillan, A et al. (1999) An antiviral mechanism of nitric oxide: inhibition of a viral protease. Immunity 10:21-8

Showing the most recent 10 out of 13 publications